Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 2530 to 2579 of 6456 in total
Value Type: Ranked
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.14285714285714\textwidth} \def\wcB{0.14285714285714\textwidth} \def\wcC{0.14285714285714\textwidth} \def\wcD{0.14285714285714\textwidth} \def\wcE{0.14285714285714\textwidth} \def\wcF{0.14285714285714\textwidth} \begin{longtable}{|c|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Network Comparison Type\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 1265\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent udp-n-acetylglucosamine--dolichyl-phosphate n- acetylglucosaminephosphotransferase (ec 2.7.8.15) (gpt) (g1pt) (n-acetylglucosamine-1-phosphate transferase) (glcnac-1-p transferase). [source:swissprot;acc:q9h3h5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1266\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial processing peptidase beta subunit, mitochondrial precursor (ec 3.4.24.64) (beta-mpp) (p-52). [source:swissprot;acc:o75439]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.635\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.575\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.06\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent rho-gtpase-activating protein 7 (rho-type gtpase-activating protein 7) (deleted in liver cancer 1 protein) (dlc-1) (hp protein) (star-related lipid transfer protein 12) (stard12) (start domain-containing protein 12). [source:swissprot;acc:q96qb1]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1267\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent map kinase-activated protein kinase 2 (ec 2.7.1.-) (mapk-activated protein kinase 2) (mapkap kinase 2) (mapkapk-2). [source:swissprot;acc:p49137]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent mitochondrial processing peptidase alpha subunit, mitochondrial precursor (ec 3.4.24.64) (alpha-mpp) (p-55) (ha1523). [source:swissprot;acc:q10713]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.634\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.576\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 5.058\vspace{3pt}}}\\\cline{1-2}\cline{4-5} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1268\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent histone-lysine n-methyltransferase, h3 lysine-9 specific 2 (ec 2.1.1.43) (histone h3-k9 methyltransferase 2) (h3-k9-hmtase 2) (suppressor of variegation 3-9 homolog 2) (su(var)3-9 homolog 2). [source:swissprot;acc:q9h5i1]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 226.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.491\vspace{3pt}}&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-6 chain precursor. [source:swissprot;acc:q15825]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1269\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 2 subunit 1 (eukaryotic translation initiation factor 2 alpha subunit) (eif-2-alpha) (eif- 2alpha) (eif-2a). [source:swissprot;acc:p05198]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.058\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent nitrogen fixation cluster-like. [source:refseq;acc:nm\_014301]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1270\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent histone-lysine n-methyltransferase, h3 lysine-9 specific 1 (ec 2.1.1.43) (histone h3-k9 methyltransferase 1) (h3-k9-hmtase 1) (suppressor of variegation 3-9 homolog 1) (su(var)3-9 homolog 1). [source:swissprot;acc:o43463]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 226.433\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 231.491\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.058\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 13 (stard13) (start domain- containing protein 13) (46h23.2). [source:swissprot;acc:q9y3m8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1271\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 8 (eif3 p110) (eif3c). [source:swissprot;acc:q99613]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 245.532\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 240.483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.049\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent star-related lipid transfer protein 8 (stard8) (start domain- containing protein 8). [source:swissprot;acc:q92502]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1272\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-2 chain precursor. [source:swissprot;acc:q15822]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent ubiquinol-cytochrome c reductase complex core protein i, mitochondrial precursor (ec 1.10.2.2). [source:swissprot;acc:p31930]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 217.624\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 212.584\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.04\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1273\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase-activated protein kinase 3; mapkap kinase 3. [source:refseq;acc:nm\_004635]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2b catalytic subunit, alpha isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, alpha isoform) (cam-prp catalytic subunit). [source:swissprot;acc:q08209]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.436\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.003\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1274\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent mitogen-activated protein kinase 14 (ec 2.7.1.37) (mitogen-activated protein kinase p38alpha) (map kinase p38alpha) (cytokine suppressive anti-inflammatory drug binding protein) (csaid binding protein) (csbp) (max-interacting protein 2) (map kinase mxi2) (sapk2a). [source:swissprot;acc:q16539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent p protein (melanocyte-specific transporter protein). [source:swissprot;acc:q04671]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.439\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5.001\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1275\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-4 chain precursor. [source:swissprot;acc:p43681]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2b catalytic subunit, gamma isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, gamma isoform) (calcineurin, testis-specific catalytic subunit) (cam-prp catalytic subunit). [source:swissprot;acc:p48454]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.441\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.441\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1276\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent neuronal acetylcholine receptor protein, alpha-3 chain precursor. [source:swissprot;acc:p32297]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine protein phosphatase 2b catalytic subunit, beta isoform (ec 3.1.3.16) (calmodulin-dependent calcineurin a subunit, beta isoform) (cam-prp catalytic subunit). [source:swissprot;acc:p16299]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.44\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 5\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1277\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dna polymerase epsilon p17 subunit (dna polymerase epsilon subunit 3) (chromatin accessibility complex 17) (huchrac17) (chrac-17). [source:swissprot;acc:q9nrf9]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 250.854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 255.842\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.988\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sphingosine kinase 2 (ec 2.7.1.-) (sk 2) (spk 2). [source:swissprot;acc:q9nra0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 171.231\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 167.177\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02425\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1278\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent heparin sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.-) (n- hsst) (n-heparin sulfate sulfotransferase) (glucosaminyl n- deacetylase/n-sulfotransferase). [source:swissprot;acc:p52849]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.934\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sestrin 3. [source:swissprot;acc:p58005]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02415\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1279\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent n-deacetylase/n-sulfotransferase (heparan glucosaminyl) 3. [source:refseq;acc:nm\_004784]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.934\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent sestrin 2 (hi95). [source:swissprot;acc:p58004]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.219\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02415\vspace{3pt}}\\\cline{1-2}\cline{5-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1280\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4a11 precursor (ec 1.14.15.3) (cypiva11) (fatty acid omega-hydroxylase) (p-450 hk omega) (lauric acid omega-hydroxylase) (cyp4aii) (p450-hl-omega). [source:swissprot;acc:q02928]\vspace{3pt}}&&&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent n-deacetylase/n-sulfotransferase 4. [source:refseq;acc:nm\_022569]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.934\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1281\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4f3 (ec 1.14.13.30) (cypivf3) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:q08477]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent heparan sulfate n-deacetylase/n-sulfotransferase (ec 2.8.2.8) (n-hsst) (hsnst) ([heparan sulfate]-glucosamine n-sulfotransferase) (n-heparan sulfate sulfotransferase) (glucosaminyl n-deacetylase/n- sulfotransferase). [source:swissprot;acc:p52848]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.934\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1282\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4f8 (ec 1.14.14.1) (cypivf8). [source:swissprot;acc:p98187]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent protein cdc27hs (cell division cycle protein 27 homolog) (h-nuc). [source:swissprot;acc:p30260]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.475\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.934\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1283\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial precursor (ec 2.3.1.12) (e2) (pdc-e2) (70 kda mitochondrial autoantigen of primary biliary cirrhosis) (pbc) (m2 antigen complex 70 kda subunit). [source:swissprot;acc:p10515]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 206.482\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 211.404\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.922\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent likely ortholog of rat cytochrome p450 4x1. [source:refseq;acc:nm\_178033]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1284\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4f12 (ec 1.14.14.1) (cypivf12). [source:swissprot;acc:q9hcs2]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent glutathione s-transferase theta 2 (ec 2.5.1.18) (gst class-theta). [source:swissprot;acc:p30712]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 228.642\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 223.726\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.916\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1285\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4f2 (ec 1.14.13.30) (cypivf2) (leukotriene-b4 omega- hydroxylase) (leukotriene-b4 20-monooxygenase) (cytochrome p450- ltb-omega). [source:swissprot;acc:p78329]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent tgf-beta receptor type i precursor (ec 2.7.1.37) (tgfr-1) (tgf-beta type i receptor) (serine/threonine-protein kinase receptor r4) (skr4) (activin receptor-like kinase 5) (alk-5). [source:swissprot;acc:p36897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.89\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 228.805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.915\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1286\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4f11 (ec 1.14.14.1) (cypivf11). [source:swissprot;acc:q9hbi6]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent serine/threonine-protein kinase receptor r2 precursor (ec 2.7.1.37) (skr2) (activin receptor-like kinase 4) (alk-4) (actr-ib). [source:swissprot;acc:p36896]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.885\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 228.797\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.912\vspace{3pt}}\\\hline \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1287\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent dj18d14.4 (cytochrome p450, subfamily iva, polypeptide 11). [source:sptrembl;acc:q9ntl5]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent neuronal calcium sensor 1 (ncs-1) (frequenin homolog) (frequenin-like protein) (frequenin-like ubiquitous protein). [source:swissprot;acc:p36610]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent 223.887\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 228.799\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.912\vspace{3pt}}\\\cline{1-2}\cline{4-6} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1288\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent activin a receptor, type ic; activin receptor-like kinase 7. [source:refseq;acc:nm\_145259]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent 223.884\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 228.795\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent 4.911\vspace{3pt}}\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent cytochrome p450 4b1 (ec 1.14.14.1) (cypivb1) (p450-hp). [source:swissprot;acc:p13584]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Divided\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 218.368\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 213.22\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 1.02414\vspace{3pt}}}\\\cline{1-2} \multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent 1289\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&&&&\\\cline{2-6} &\parbox{\wcB}{\vspace{3pt}\noindent peroxisomal n1-acetyl-spermine/spermidine oxidase. [source:refseq;acc:nm\_152911]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent Subtracted\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 228.644\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 223.736\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent 4.908\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 1290\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atpase inhibitor, mitochondrial precursor. [source:swissprot;acc:q9uii2]\vspace{3pt}}&&&&\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/